MedPath

Multicenter and Open Pilot Clinical Study on the Safety of a New One-piece Convex Appliance in Patients With Enterostomy

Not Applicable
Completed
Conditions
Enterostomy
Interventions
Device: Flexima Active soft convexe
Registration Number
NCT02507726
Lead Sponsor
BBraun Medical SAS
Brief Summary

This study evaluates the performance of a new 1-piece ostomy convex appliance in patients with enterostomy.

Detailed Description

Primary outcome Measure:

To describe Investigational Device performance in term of level of leakage under the skin protector

Secondary Outcome Measure:

* Assessment of the condition of peristomal skin

* Assessment of other performance criteria

* Assessment of AEs for each patient

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • patient is at least 18 years old,
  • patient having a colostomy or an ileostomy for at least 1 month,
  • patient having a stoma's diameter inferior to 45 mm,
  • patient having a flat or flushed or slightly retracted stoma,
  • patient using currently a one-piece soft convex or standard ostomy appliance with closed or drainable bags,
  • patient using a minimum of 1 product per day with closed pouches or minimum 1 product per two days with drainable pouches
  • patient capable to apply and remove the pouch himself or with the help of a caregiver (except health care professional)
  • patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions)
  • patient agreeing to test investigational product during 14(±3) days.
  • patient covered by social security
Exclusion Criteria
  • patient experiencing repeated leakages with his current appliance,
  • patient receiving or having received, within the last month, chemotherapy or radiotherapy or corticotherapy,
  • patient having a deeply retracted stoma,
  • patient currently suffering from peristomal skin complications (bleeding or severe irritation or red and broken skin at the time of inclusion),
  • patient already participating in another clinical study or who have previously participated in this investigation,
  • pregnant or breast-feeding woman

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Flexima Active Soft convexeFlexima Active soft convexeFlexima Active soft convexe (1 to 3 appliances per day)
Primary Outcome Measures
NameTimeMethod
Flexima® Active Soft Convex ostomy appliance performance description in term of level of leakage under the skin protector14 +- 3 days
Secondary Outcome Measures
NameTimeMethod
Peristomal skin evaluation with DET score scalebaseline and 14 +- 3 days
Investigational product conformability as measured by a Likert scale score (1-4)14 +- 3 days
Use of Investigational Product in the future as measured by a Likert scale score (1-2)14 +- 3 days
Residues on the skin after each Investigational Product removal as measured by a Likert scale score (1-4)14 +- 3 days
Ease of Investigational Product handling as measured by a Likert scale score (1-4)14 +- 3 days
Investigational product adhesivity as measured by a Likert scale score (1-4)14 +- 3 days
Convex ring suppleness of the Investigational product as measured by a Likert scale score (1-4)14 +- 3 days
Investigational Product leakage prevention as measured by a Likert scale score (1-4)14 +- 3 days
Investigational Product overall satisfaction as measured by a Likert scale score (1-4)14 +- 3 days
Number of Participants with Adverse Events as a Measure of Safety and Tolerabilitybaseline and 14 +- 3 days
Investigational product flexibility as measured by a Likert scale score (1-4)14 +- 3 days
Feeling of Investigational Product security as measured by a Likert scale score (1-4)14 +- 3 days
Investigational product wear time14 +- 3 days

The patient will complete his patient diary after each Investigational Product removal

Connection of the Investigational Product belt to the belt hear as measured by a Likert scale score (1-4)14 +- 3 days
Investigational Product wearing comfort as measured by a Likert scale score (1-4)14 +- 3 days

Trial Locations

Locations (1)

Patrick RAT

🇫🇷

Dijon, France

© Copyright 2025. All Rights Reserved by MedPath